Conditions: HR+/HER2- aBC Undergoing 1L Treatment With CDK4/6i (Palbociclib, Abemaciclib or Ribociclib) and AI (Anastrozole or Letrozole)
Interventions: Diagnostic Test: ESR1 testing
Sponsors: Institut fuer Frauengesundheit; AGO Breast (Arbeitsgemeinschaft Gynäkologische Onkologie); data4treat GmbH; BioMedStatistics GmbH; ClinSol GmbH & Co KG; Universitätsklinikum Erlangen
Not yet recruiting Conditions: HR+/HER2- aBC Undergoing 1L Treatment With CDK4/6i (Palbociclib, Abemaciclib or Ribociclib) and AI (Anastrozole or Letrozole)
Interventions: Diagnostic Test: ESR1 testing
Sponsors: Institut fuer Frauengesundheit; AGO Breast (Arbeitsgemeinschaft Gynäkologische Onkologie); data4treat GmbH; BioMedStatistics GmbH; ClinSol GmbH & Co KG; Universitätsklinikum Erlangen
Not yet recruiting
